Related Experiment Video
Updated: May 7, 2025

12:28
Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
Published on: June 3, 2020
17.1K
Development and longitudinal neurocognitive functioning in mucopolysaccharidosis type IIIC: a case study
Paulina Anikiej-Wiczenbach1, Monika Limanówka2, Maria Mazurkiewicz-Bełdzińska2
1Psychological Counselling for Rare Genetic Diseases, Institute of Psychology, Faculty of Social Science, University of Gdansk, Bażynskiego, 4, 80-309, Gdańsk, Poland. paulina.anikiej@ug.edu.pl.
Journal of Applied Genetics
|December 31, 2024
Summary
This study examines a child with mucopolysaccharidosis type IIIC (MPS IIIC), showing milder symptoms than expected. Individual variability in MPS IIIC progression is crucial, even with severe genetic markers.
Area of Science:
- Biochemistry
- Genetics
- Neuroscience
Background:
- Mucopolysaccharidosis type IIIC (MPS IIIC) is a rare genetic disorder.
- It is caused by mutations in the HGSNAT gene, leading to neurodegeneration.
- Clinical presentation and progression of MPS IIIC can vary significantly.
Purpose of the Study:
- To analyze the neurocognitive, medical, and developmental functioning of a 9-year-old girl with MPS IIIC.
- To investigate the correlation between genetic profile, enzyme levels, and clinical presentation.
- To highlight the variability in MPS IIIC progression.
Main Methods:
- Case study analysis.
- Genetic testing for HGSNAT gene variants.
- Neuropsychological assessment.
- Brain magnetic resonance imaging (MRI).
Main Results:
- The patient has a homozygous pathogenic HGSNAT variant (c.1872C>A) but a milder clinical course than expected.
- Moderate intellectual disability was observed, with a stable developmental age for 3 years.
- Cognitive skills remained stable, except for a decline in working memory; MRI showed no abnormalities.
Conclusions:
- MPS IIIC progression is complex and highly variable, even with severe genetic markers.
- Early diagnosis, regular monitoring, and a multidisciplinary approach are essential for managing MPS IIIC.
- Individual variability must be considered in predicting MPS IIIC outcomes.
Keywords:
HGSNAT geneLysosomal storage disordersNeurocognitive assessmentNeurodevelopmental disordersSanfilippo disease
